CompuMed, Inc. (CMPD)
USD 3.53
(-1.94%)
USD 3.53
(-1.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -32.6 Thousand USD | -106.5% |
| 2022 | 501.85 Thousand USD | -52.97% |
| 2021 | 1.06 Million USD | 215.32% |
| 2020 | 338.43 Thousand USD | -65.25% |
| 2019 | 973.78 Thousand USD | 343.76% |
| 2018 | 219.44 Thousand USD | 158.33% |
| 2017 | 84.94 Thousand USD | 163.19% |
| 2016 | -134.42 Thousand USD | 0.0% |
| 2011 | -119 Thousand USD | 68.52% |
| 2010 | -378 Thousand USD | -48.24% |
| 2009 | -255 Thousand USD | 83.53% |
| 2008 | -1.54 Million USD | 10.78% |
| 2007 | -1.73 Million USD | -309.2% |
| 2006 | -424 Thousand USD | -26.19% |
| 2005 | -336 Thousand USD | -22.18% |
| 2004 | -275 Thousand USD | 26.67% |
| 2003 | -375 Thousand USD | 24.09% |
| 2002 | -494 Thousand USD | 44.93% |
| 2001 | -897 Thousand USD | 37.92% |
| 2000 | -1.44 Million USD | -31.36% |
| 1999 | -1.1 Million USD | 15.38% |
| 1998 | -1.3 Million USD | 40.91% |
| 1997 | -2.2 Million USD | 52.17% |
| 1996 | -4.6 Million USD | -35.29% |
| 1995 | -3.4 Million USD | 12.82% |
| 1994 | -3.9 Million USD | -77.27% |
| 1993 | -2.2 Million USD | -10.0% |
| 1992 | -2 Million USD | -300.0% |
| 1991 | -500 Thousand USD | -400.0% |
| 1990 | -100 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4009.00 USD | 82.85% |
| 2024 Q3 | 100.92 Thousand USD | 46.16% |
| 2024 Q2 | 69.04 Thousand USD | 1822.3% |
| 2023 Q2 | -39.89 Thousand USD | -406.92% |
| 2023 FY | -32.6 Thousand USD | -106.5% |
| 2023 Q4 | -23.38 Thousand USD | -232.32% |
| 2023 Q3 | 17.67 Thousand USD | 144.3% |
| 2023 Q1 | 12.99 Thousand USD | -94.38% |
| 2022 Q4 | 231.2 Thousand USD | 87.73% |
| 2022 Q2 | 38.99 Thousand USD | -64.06% |
| 2022 Q1 | 108.49 Thousand USD | -77.42% |
| 2022 Q3 | 123.16 Thousand USD | 215.84% |
| 2022 FY | 501.85 Thousand USD | -52.97% |
| 2021 Q3 | 236.42 Thousand USD | 64.3% |
| 2021 Q4 | 480.44 Thousand USD | 103.21% |
| 2021 FY | 1.06 Million USD | 215.32% |
| 2021 Q2 | 143.9 Thousand USD | 0.0% |
| 2020 FY | 338.43 Thousand USD | -65.25% |
| 2019 FY | 973.78 Thousand USD | 343.76% |
| 2018 FY | 219.44 Thousand USD | 158.33% |
| 2017 FY | 84.94 Thousand USD | 163.19% |
| 2016 FY | -134.42 Thousand USD | 0.0% |
| 2011 Q4 | 3000.00 USD | -88.89% |
| 2011 FY | -119 Thousand USD | 68.52% |
| 2011 Q3 | 27 Thousand USD | 154.0% |
| 2011 Q1 | -101 Thousand USD | -53.03% |
| 2011 Q2 | -50 Thousand USD | 50.5% |
| 2010 FY | -378 Thousand USD | -48.24% |
| 2010 Q1 | -155 Thousand USD | -150.0% |
| 2010 Q2 | -68 Thousand USD | 56.13% |
| 2010 Q3 | -89 Thousand USD | -30.88% |
| 2010 Q4 | -66 Thousand USD | 25.84% |
| 2009 Q2 | - USD | 100.0% |
| 2009 FY | -255 Thousand USD | 83.53% |
| 2009 Q3 | -49 Thousand USD | 0.0% |
| 2009 Q4 | -62 Thousand USD | -26.53% |
| 2009 Q1 | -142 Thousand USD | 56.44% |
| 2008 FY | -1.54 Million USD | 10.78% |
| 2008 Q4 | -326 Thousand USD | -127.97% |
| 2008 Q3 | -143 Thousand USD | 74.82% |
| 2008 Q2 | -568 Thousand USD | -28.8% |
| 2008 Q1 | -441 Thousand USD | 49.71% |
| 2007 Q2 | -107 Thousand USD | 51.36% |
| 2007 FY | -1.73 Million USD | -309.2% |
| 2007 Q4 | -877 Thousand USD | -398.3% |
| 2007 Q3 | -176 Thousand USD | -64.49% |
| 2007 Q1 | -220 Thousand USD | -44.74% |
| 2006 Q1 | -41 Thousand USD | 74.21% |
| 2006 Q3 | -130 Thousand USD | -28.71% |
| 2006 FY | -424 Thousand USD | -26.19% |
| 2006 Q4 | -152 Thousand USD | -16.92% |
| 2006 Q2 | -101 Thousand USD | -146.34% |
| 2005 Q3 | -51 Thousand USD | -54.55% |
| 2005 FY | -336 Thousand USD | -22.18% |
| 2005 Q4 | -159 Thousand USD | -211.76% |
| 2005 Q1 | -93 Thousand USD | 2.11% |
| 2005 Q2 | -33 Thousand USD | 64.52% |
| 2004 Q2 | -79 Thousand USD | -29.51% |
| 2004 Q4 | -95 Thousand USD | -137.5% |
| 2004 Q3 | -40 Thousand USD | 49.37% |
| 2004 Q1 | -61 Thousand USD | 49.17% |
| 2004 FY | -275 Thousand USD | 26.67% |
| 2003 Q4 | -120 Thousand USD | -150.0% |
| 2003 FY | -375 Thousand USD | 24.09% |
| 2003 Q2 | -59 Thousand USD | 59.86% |
| 2003 Q1 | -147 Thousand USD | -873.68% |
| 2003 Q3 | -48 Thousand USD | 18.64% |
| 2002 FY | -494 Thousand USD | 44.93% |
| 2002 Q3 | -290 Thousand USD | -267.09% |
| 2002 Q4 | 19 Thousand USD | 106.55% |
| 2002 Q1 | -144 Thousand USD | 5.88% |
| 2002 Q2 | -79 Thousand USD | 45.14% |
| 2001 FY | -897 Thousand USD | 37.92% |
| 2001 Q4 | -153 Thousand USD | -21.43% |
| 2001 Q3 | -126 Thousand USD | 47.28% |
| 2001 Q2 | -239 Thousand USD | 36.94% |
| 2001 Q1 | -379 Thousand USD | 36.52% |
| 2000 Q3 | -414 Thousand USD | -101.95% |
| 2000 FY | -1.44 Million USD | -31.36% |
| 2000 Q2 | -205 Thousand USD | -2.5% |
| 2000 Q4 | -597 Thousand USD | -44.2% |
| 2000 Q1 | -200 Thousand USD | 33.33% |
| 1999 Q2 | -200 Thousand USD | 33.33% |
| 1999 FY | -1.1 Million USD | 15.38% |
| 1999 Q4 | -300 Thousand USD | -50.0% |
| 1999 Q3 | -200 Thousand USD | 0.0% |
| 1999 Q1 | -300 Thousand USD | -200.0% |
| 1998 Q1 | -500 Thousand USD | 0.0% |
| 1998 FY | -1.3 Million USD | 40.91% |
| 1998 Q4 | -100 Thousand USD | 66.67% |
| 1998 Q3 | -300 Thousand USD | 25.0% |
| 1998 Q2 | -400 Thousand USD | 20.0% |
| 1997 Q4 | -500 Thousand USD | 0.0% |
| 1997 Q3 | -500 Thousand USD | 16.67% |
| 1997 Q2 | -600 Thousand USD | -20.0% |
| 1997 Q1 | -500 Thousand USD | 0.0% |
| 1997 FY | -2.2 Million USD | 52.17% |
| 1996 Q2 | -600 Thousand USD | 0.0% |
| 1996 FY | -4.6 Million USD | -35.29% |
| 1996 Q1 | -600 Thousand USD | 73.91% |
| 1996 Q4 | -500 Thousand USD | 82.76% |
| 1996 Q3 | -2.9 Million USD | -383.33% |
| 1995 Q1 | -300 Thousand USD | 25.0% |
| 1995 FY | -3.4 Million USD | 12.82% |
| 1995 Q3 | -300 Thousand USD | 40.0% |
| 1995 Q4 | -2.3 Million USD | -666.67% |
| 1995 Q2 | -500 Thousand USD | -66.67% |
| 1994 Q3 | -600 Thousand USD | 76.0% |
| 1994 Q4 | -400 Thousand USD | 33.33% |
| 1994 Q2 | -2.5 Million USD | -733.33% |
| 1994 Q1 | -300 Thousand USD | 57.14% |
| 1994 FY | -3.9 Million USD | -77.27% |
| 1993 Q3 | -400 Thousand USD | 0.0% |
| 1993 Q4 | -700 Thousand USD | -75.0% |
| 1993 FY | -2.2 Million USD | -10.0% |
| 1993 Q2 | -400 Thousand USD | 42.86% |
| 1993 Q1 | -700 Thousand USD | -16.67% |
| 1992 Q1 | - USD | 0.0% |
| 1992 FY | -2 Million USD | -300.0% |
| 1992 Q4 | -600 Thousand USD | 0.0% |
| 1992 Q2 | -600 Thousand USD | 0.0% |
| 1992 Q3 | -600 Thousand USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 FY | -500 Thousand USD | -400.0% |
| 1991 Q3 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 FY | -100 Thousand USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Achiko AG | -9.32 Million USD | 99.65% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -5.18 Million USD | 99.372% |
| Cannabis Sativa, Inc. | -1.39 Million USD | 97.658% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million USD | 100.071% |
| Cogstate Limited | 5.44 Million USD | 100.598% |
| CareView Communications, Inc. | -3.95 Million USD | 99.175% |
| Craneware plc | 11.7 Million USD | 100.279% |
| Caduceus Software Systems Corp. | -13.96 Million USD | 99.766% |
| Certive Solutions Inc. | -1.67 Million USD | 98.048% |
| Drug Free Solution, Inc. | -1.4 Million USD | 97.683% |
| DATATRAK International, Inc. | 2.65 Million USD | 101.227% |
| Strainsforpains, Inc. | -182.18 Thousand USD | 82.104% |
| Healixa Inc. | -6.73 Million USD | 99.516% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 7.1 Million USD | 100.459% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -702.48 Thousand USD | 95.359% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -789.33 USD | -4030.592% |
| IQ-AI Limited | -623.81 Thousand USD | 94.773% |
| Cannabiz Mobile, Inc. | -750.00 USD | -4247.2% |
| Mednow Inc. | -29.48 Million USD | 99.889% |
| Galileo Life Sciences, Inc. | -248.24 Thousand USD | 86.866% |
| MediXall Group, Inc. | -6.83 Million USD | 99.523% |
| Mitesco, Inc. | -13.33 Million USD | 99.755% |
| MobileSmith, Inc. | -14.12 Million USD | 99.769% |
| NantHealth, Inc. | -67.77 Million USD | 99.952% |
| Net Medical Xpress Solutions, Inc. | -1.85 Million USD | 98.244% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -13.38 Million USD | 99.756% |
| Patient Access Solutions, Inc. | -10.59 Million USD | 99.692% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 102.489% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 143.63% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 4.39% |
| Renalytix Plc | -33.45 Million USD | 99.903% |
| Revium Recovery Inc. | -683 Thousand USD | 95.226% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 313.06 Thousand USD | 110.415% |
| Vaso Corporation | 4.8 Million USD | 100.679% |
| Vynleads, Inc. | -263.43 Thousand USD | 87.624% |